The Weekly Roundup: October 14-18

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Conference Speaker Sneak Peek: Elevate-Derm

Review insights from expert faculty as they look forward to the upcoming Elevate-Derm conference.

Neoadjuvant Intralesional 5-Fluorouracil Injection: Improved SCC Treatment in Older Patients

In October's cover feature, Nicole A. Negbenebor, MD, FAAD, discusses the benefits of intralesional 5-fluorouracil injection for older patients with squamous cell carcinoma who may elect to delay therapy or are not ideal candidates for surgery.

Study Evaluates Training Tool Developed for PCP Psoriasis Diagnosis

Researchers behind the study emphasized the urgent need to enhance the diagnostic skills of primary care practitioners to improve early detection of psoriasis.

Trial Evaluates Efficacy of Brevilin-A in Treating Pediatric AA

Researchers behind the trial saw a decrease in the Severity of Alopecia Tool (SALT) score from 31 to 11.2 after 3 months of treatment with brevilin-A.

Jessica Hui, MD: Non-Visible Considerations for Eczema Management

Hui addresses one of the NEA's Eczema Awareness Month weekly themes, "Eczema is more than the visuals."

Fostering Collaboration and Mentorship in Dermatology

Renata Block, PA-C, and Karan Lal, DO, discuss the critical role of advanced practice providers in dermatology, the power of mentorship, and how collaborative learning improves patient outcomes.

Vitiligo Identified as Possible Risk Factor for Cardiovascular Disease

Investigators noted that further research is needed to monitor the prevalence of cardiovascular disease in patients with vitiligo.

Optimizing Patient Communication and Treatment Efficacy Beyond Topical Steroids

Omar Noor, MD, FAAD, hosted a live Case-Based Roundtable discussion with local dermatology clinicians to discuss 2 patients with plaque psoriasis and what would be the ideal topical treatment for each.

LEO Pharma's Delgocitinib Launches for Chronic Hand Eczema in Germany

Germany is now the first country to launch the topical treatment for adults with moderate to severe CHE.

Almirall Completes Decentralized Regulatory Approval Procedure for Efinaconazole in Europe

Efinaconazole demonstrated enhanced efficacy in treating nail fungal infections, thanks to its high penetration capability and low keratin binding.

Exploring Roflumilast Cream 0.3% for Refractory Palmoplantar Pustulosis

An 82-year-old woman with PPP and treated with roflumilast cream 0.3% achieved complete clearance after 5 weeks of treatment.

ALPHA Study Finds Alitretinoin Is Fast, Effective for CHE Treatment

ALPHA compared alitretinoin and phototherapy for speed and efficacy when treating chronic hand eczema.

FDA Clears Accure’s Laser System for Long-Term Treatment of Acne

This new indication adds to existing clearance of a non-drug treatment for mild to severe inflammatory acne vulgaris.

Bimekizumab vs. Risankizumab: BE BOLD Study Insights with Jeff Stark

The study design emphasizes elevated endpoints, particularly joint health, ensuring that the most relevant outcomes are prioritized for patient care.

Chris Robb, MD, PhD, FAAD: Insights on the Latest Innovations in Skin Treatment Technology With BBL HEROic

Robb delved into how the system is transforming skin treatments with advanced precision, faster results, and improved patient outcomes.

FDA Approves 320 mg Bimekizumab Pre-Filled Syringe and Autoinjector

The new delivery systems for bimekizumab-bkzx represent an upgrade over previous 1 mL options, reducing the frequency of injections required.

Clinical Pearls for Vitiligo and Pigmentation Complexities: Part 2

In a Dermatology Times Case-Based Roundtable event, Chesahna Kindred, MD, MBA, FAAD, reviewed 2 cases of patients with vitiligo treated with ruxolitinib cream.

The Changing Face of Aesthetics

Along with this new transparency regarding treatments, patients are empowered to embrace more comprehensive beauty ideals.

Artificial Intelligence App Shows Promise in Detecting Skin Changes

The app demonstrated high sensitivity (92.0%) and specificity (95.5%) in identifying skin changes through a controlled testing environment.

Teledermatology on Par with Clinic Dermatology, New Review Finds

Although further research is still needed, dermatologists and patients are generally satisfied with teledermatology treatment.

SkylineDx Data Confirms Accuracy of the Merlin Test for Low- and High-Risk Melanoma

Results from Society for Melanoma Research Congress demonstrated excellent predictive power of noninvasive CP-GEP Merlin test.

Eyelashes: Hair Today, Gone Tomorrow

In this month's Cosmetic Conundrums column, explore 4 eyelash growth scenarios.

A Holistic Approach to Assessing and Enhancing Skin Quality

Developed by a panel of global dermatology experts, the SQS addresses the multifaceted nature of skin quality.

Study Quantifies, Characterizes Health Care Burden of Prurigo Nodularis in England

The study represents the first to evaluate health care resource utilization among individuals with PN in England.

Understanding the Role of Micronutrients in Vitiligo

Studies show conflicting serum levels of zinc and copper in vitiligo patients, indicating a need for further research.

Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis

With this combined administration, patients saw noticeable and lasting improvements in severe cases of AD.

Addressing Challenging Cases of Acne: Part 2

In a Dermatology Times Case-Based Roundtable event, James Del Rosso, DO, shared pearls for challenging acne cases.

Summer Forlenza, LMFT: Patient Resources for Breaking the Stress Cycle

Forlenza addresses one of the NEA's Eczema Awareness Month weekly themes, "Tools for living your most ecz-pressive life with eczema."

Dupilumab in Hyper-IgE Syndrome: A Case Series of Pediatric Patients

The case series found dupilumab led to improvements in skin condition and a reduction in bacterial infections for pediatric patients with Hyper-IgE syndrome.

Health Canada Approves Roflumilast Foam 0.3% for Patients 9 Years and Older With Seborrheic Dermatitis

This represents the second approval of Zoryve outside the US.

New Treatments Enhance Care for Diverse Range of Patients With Psoriasis

Historically, research and clinical practice often have overlooked the distinct manifestations and treatment needs of patients with skin of color who have psoriasis.

Omalizumab Safe and Effective for CIndU Treatment, UCARE Study Finds

The multicenter trial reported high response rates and low risk of discontinuation for treating long-term chronic inducible urticaria.